Nov 22 (Reuters) - Lexicon Pharmaceuticals said on Friday it would reduce its workforce by about 60%, effective Dec. 31, to eliminate commercial activities and focus on drug development.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas)
((Mariam.ESunny@thomsonreuters.com;))